Biotronik starts US trials for dual-chamber ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
Biotronik has begun clinical trials in the US of its Phylax AV dual-chamber implantable cardioverter defibrillator. A total of 15 sites will take part in the study and the device was implanted in the first group of patients earlier this month. The Phylax AV uses Smart detection technology to discriminate activity in the atria and ventricles and to provide the appropriate treatment. The Lake Oswega, Oregon-based company,i which has already CE-marked the product, plans to submit the data from these trials for FDA approval later this year.